Date: 22.9.2014
Technology offer: Vaccinal Nanovector approach for prophylaxis or treatment of an allergy
Reference: 13 FR 34k3 3SOB
Summary: A French research Institute has developed new class of lipid vector for intracellular vaccination using DNA molecule coding for the antigen of asthma. The aim is to produce a prophylactic or therapeutic vaccine. The vaccine administration in animal model led to a reduction of airway hyperresponsiveness and a significant decrease of inflammatory cytokines in the bronchoalveolar lavage. Industrial partners are sought in order to co-develop asthma and rhinitis allergy applications.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Africa Biotech - Biotechnology and African Agriculture news
Life Sciences Search engine - Huge database of genome, protein, gene, genome project, ..
More than 30 new species of bacteria discovered in patient samples
Enhanced CRISPR method enables stable insertion of large genes into the DNA of higher plants